Cargando…

Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes?

Detalles Bibliográficos
Autores principales:	Atkinson, Mark A, Powers, Alvin C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766204/ https://www.ncbi.nlm.nih.gov/pubmed/33838106 http://dx.doi.org/10.1016/S2213-8587(21)00087-5

Ejemplares similares

Dexamethasone-induced hyperglycaemia in COVID-19: Glycaemic profile in patients without diabetes and factors associated with hyperglycaemia
por: Rhou, Yoon Ji J, et al.
Publicado: (2022)

Why does the sepsis induced by severe COVID-19 have different clinical features from sepsis induced by CrKP?
por: Lin, Hong-Yuan
Publicado: (2022)

Evaluating COVID-19 vaccines in the real world
por: Mills, Edward J, et al.
Publicado: (2022)

What does endemic COVID-19 mean for the future of rituximab?
por: Liew, David F L, et al.
Publicado: (2022)

Practical early cancer detection: distinguishing stable from unstable genomes in pre-cancerous tissues
por: Killcoyne, Sarah, et al.
Publicado: (2020)

Real-world effectiveness of oral antivirals for COVID-19
por: Burdet, Charles, et al.
Publicado: (2022)

Does Smoking Protect against Being Hospitalized for COVID-19?
por: Berlin, Ivan, et al.
Publicado: (2020)

Does post COVID-19 characterize new diseases and disabilities?
por: Chakrovorty, Sonjit Kumar, et al.
Publicado: (2023)

COVID‐19 and dexamethasone‐induced hyperglycaemia: Workload implications for diabetes inpatient teams
por: Younes, Younes R., et al.
Publicado: (2021)

Real-time COVID-19 forecasting: challenges and opportunities of model performance and translation
por: Nixon, Kristen, et al.
Publicado: (2022)

Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes
por: Barker, Hannah L., et al.
Publicado: (2023)

Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients
por: Funnell, S. G. P., et al.
Publicado: (2020)

Host gene signature shows promise to distinguish bacterial and viral infections
por: Channon-Wells, Samuel, et al.
Publicado: (2021)

Does Vitamin D play a role in the management of Covid-19 in Brazil?
por: Ribeiro, Helena, et al.
Publicado: (2020)

Understanding COVID-19: what does viral RNA load really mean?
por: Joynt, Gavin M, et al.
Publicado: (2020)

Distinguishing between thyroid and parathyroid nodules by ultrasound: a potential game-changer in clinical practice?
por: Juhlin, C. Christofer, et al.
Publicado: (2023)

Symptom study app provides real-world data on COVID-19 vaccines
por: Drury, Ruth E, et al.
Publicado: (2021)

If not now, when? COVID-19, lived experience, and a moment for real change
por: Jones, Nev, et al.
Publicado: (2020)

Glucocorticoid‐induced hyperglycaemia and diabetes: Call for action
por: Golubic, Rajna, et al.
Publicado: (2022)

The effect of COVID-19 on routine diabetes care and mortality in people with diabetes
por: Hopkins, David, et al.
Publicado: (2022)

Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
por: Bechman, Katie, et al.
Publicado: (2023)

Observational research on severe COVID-19 in diabetes
por: Stehouwer, Coen D A
Publicado: (2021)

How does diabetes mellitus impact on the prognosis of dental implants?
por: Baniulyte, Gabriele, et al.
Publicado: (2023)

Distinguishing Prevention from Treatment in Suicide Prevention. Comment on Turner et al. The Paradox of Suicide Prevention. Int. J. Environ. Res. Public Health 2022, 19, 14983
por: Obegi, Joseph H.
Publicado: (2023)

Hyperglycaemia on admission to hospital and COVID-19
por: Sardu, Celestino, et al.
Publicado: (2020)

Tissue damage from neutrophil-induced oxidative stress in COVID-19
por: Laforge, Mireille, et al.
Publicado: (2020)

Diabetic ketoacidosis risk during the COVID-19 pandemic
por: Vellanki, Priyathama, et al.
Publicado: (2021)

Diabetes, like COVID-19, is a wicked problem
por: Kerr, David, et al.
Publicado: (2020)

Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
por: Calcutt, Nigel A., et al.
Publicado: (2009)

Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia
por: Laurenzi, Andrea, et al.
Publicado: (2021)

Metformin: an inexpensive and effective treatment in people with diabetes and COVID-19?
por: Dardano, Angela, et al.
Publicado: (2021)

Diabetes and covid-19: more than the sum of two morbidities
por: Pititto, Bianca de Almeida, et al.
Publicado: (2020)

Dysregulation of 2-oxoglutarate-dependent dioxygenases by hyperglycaemia: does this link diabetes and vascular disease?
por: Green, Hannah L. H., et al.
Publicado: (2020)

Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data
por: De Vito, Andrea, et al.
Publicado: (2023)

Rise in diabetic ketoacidosis during the COVID-19 pandemic: several questions remain
por: Misra, Shivani
Publicado: (2022)

Does clozapine treat antipsychotic-induced behavioural supersensitivity through glutamate modulation within the striatum?
por: Tibrewal, Prashant, et al.
Publicado: (2023)

Investigating the Evidence of the Real-Life Impact of Acute Hyperglycaemia
por: Heller, Simon, et al.
Publicado: (2015)

Hyperglycaemia, glycosuria and ketonuria may not be diabetes.
por: Gray, J., et al.
Publicado: (2003)

Cigarette Smoking and Hyperglycaemia in Diabetic Patients
por: Sari, Mutiara Indah, et al.
Publicado: (2018)

COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way
por: Danne, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aju6cv65t9blu8vp27ue74n030